Clinical Trial Update: Effect of LOW-molecular-weight Heparin in Reducing Radial Artery Occlusion Rate After Transradial Coronary Catheterization [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of low-molecular-weight heparin on reducing radial artery occlusion after transradial coronary catheterization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Occlusion

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: AHEPA University Hospital | Conditions: Arterial Occlusion | Phase 4 | Status: COMPLETED